Bosentan reduces the number of new digital ulcers in patients with systemic sclerosis open label extension to a double-blind trialCasilda G. Black, Korn Jh, CP Denton et al.|UCL Discovery (University College London)|2006Cited by 6
Gastric antral vascular ectasia (GAVE) in early diffuse SSc: Report from the SCOT trialK. Sullivan, Mayes, D. H. Wallace et al.|Arthritis & Rheumatism|2008Cited by 4
TYK2 and Systemic Sclerosis Susceptibility: a New Associated Locus in the IL-12 PathwayElena López‐Isac, Shervin Assassi, C.P. Simeón et al.|Kölner Universitäts PublikationsServer (Universität zu Köln)|2015Cited by 0
Functional correlates of reduction of digital ulcers by Bosentan therapy in patients with systemic sclerosis (SSC)Janet Pope, Seibold, Casilda G. Black et al.|UCL Discovery (University College London)|2006Cited by 0